-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on AngioDynamics (ANGO)
-
-
-
-
-
-
-
AngioDynamics to Report Fiscal 2025 Fourth Quarter and Full-Year Financial Results on Tuesday, July 15, 2025
-
-
-
-
-
-
-
AngioDynamics (ANGO) Tops Q2 EPS by 7c; updates guidance
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on AngioDynamics (ANGO)
-
-
-
-
-
-
-
AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
-
-
-
-
-
-
-
AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance
-
-
-
-
-
-
-
AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million
-
1,199,634 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

